MSII, Howard University College of Medicine, 520 W St NW, Washington, DC 20059, USA.
Professor, Department of Medicine, Howard University College of Medicine, Washington, DC 20059 USA.
J Natl Med Assoc. 2023 Jun;115(3):314-318. doi: 10.1016/j.jnma.2023.03.002. Epub 2023 Apr 5.
In the US, little is known about aspirin use as a preventive measure for cardiovascular disease by immigration status.
Combined data from the National Health and Nutrition Examination Survey (NHANES) 2015-2016 and 2017- March 2020 (pre-pandemic data) were analyzed. Persons were asked about demographics including country of birth and those aged 40 years and older were asked about current use of aspirin to prevent cardiovascular disease (CVD).
Among 2,321 born in the US, preventive aspirin use was significantly more prevalent (39.6%) than among 910 others (27.5%, p < 0.01). However, after stratifying by race/ethnicity and history of CVD, the difference was significant only in Hispanics with CVD. In logistic regression analyses in Hispanics controlling for age, gender and education, the US born had significantly higher odds of aspirin use in those with or without CVD.
Among US Hispanics, use of aspirin for prevention of CVD was more prevalent in those born in the US than in others.
在美国，人们对不同移民身份人群使用阿司匹林预防心血管疾病的情况知之甚少。
对 2015-2016 年和 2017 年至 2020 年 3 月（大流行前数据）的国家健康和营养检查调查（NHANES）合并数据进行了分析。调查询问了参与者的人口统计学信息，包括出生地，年龄在 40 岁及以上的人被问及是否使用阿司匹林预防心血管疾病（CVD）。
在 2321 名在美国出生的人中，预防性使用阿司匹林的比例（39.6%）明显高于 910 名非美国出生的人（27.5%，p < 0.01）。然而，在按种族/族裔和心血管疾病史分层后，这种差异仅在患有心血管疾病的西班牙裔中显著。在对西班牙裔人群进行的多变量逻辑回归分析中，控制年龄、性别和教育程度后，有或没有心血管疾病的美国出生人群使用阿司匹林的几率明显更高。
在美国西班牙裔中，与非美国出生者相比，那些出生在美国的人更倾向于使用阿司匹林预防 CVD。
